Clinical trial
Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic…
NCT00027664 · Cancer Research UK, Other · Unknown status
Key facts
| NCT number | NCT00027664 |
|---|---|
| Title | Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer |
| Official title | Interferon Alpha In Combination With Thalidomide In The Treatment Of Metastatic Renal Cell Carcinoma A Randomized Phase II Study |
| Lead sponsor | Cancer Research UK, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Biological, Drug |
| Interventions | recombinant interferon alfa, thalidomide |
| Enrollment | 90 |
| Start date | Feb 1, 2001 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 7, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: